{"id":"vehicle-versus-nb-001","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Injection site pain"}]},"_chembl":{"chemblId":"CHEMBL2108661","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"NB-001 is a vaccine that works by stimulating an immune response against a specific target, but the exact mechanism is not publicly disclosed.","oneSentence":"NB-001 is a vaccine.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:40:24.017Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Influenza"}]},"trialDetails":[{"nctId":"NCT01321359","phase":"PHASE3","title":"A Multicenter Study of NB-001 in the Treatment of Recurrent Herpes Labialis","status":"COMPLETED","sponsor":"NanoBio Corporation","startDate":"2011-04","conditions":"Recurrent Herpes Simplex Labialis","enrollment":907}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Vehicle versus NB-001","genericName":"Vehicle versus NB-001","companyName":"NanoBio Corporation","companyId":"nanobio-corporation","modality":"Small molecule","firstApprovalDate":"","aiSummary":"NB-001 is a vaccine. Used for Influenza.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}